A private investment opportunity in two scalable health ventures: GLP-1 weight-loss platform and nutraceutical wellness.

Lorem ipsum dolor sit amet.

Transforming Wellness Through Investment

Unlock the opportunity

Two Ventures.
One Vision for Scalable Health Growth

  • Envigore Investment
  • 1
  • Rising UK-based e-pharmacy for GLP-1 treatments.
  • Expanding access to breakthrough weight-loss care.
  • Reakiro Investment
  • 2
  • European leader in wellness innovation.
  • Expanding access to breakthrough weight-loss care.
  • 3-year term Health45 Bond
  • 3
  • Capital-secured investment.
0
  • % fixed return

A Growing Health Crisis
and Unmet Demand

Nutraceuticals grew
by 8.2% CAGR last year.

Wellness is now a consumer default.

63% of UK adults are classified
as overweight or obese

Public systems are overburdened, leaving millions underserved.
Breakthrough GLP-1 medications are effective but under-distributed.

Innovation Driving Retention and Growth

Digital infrastructure connects directly with consumers

Global footprint across 15+ countries

Structured
returns

ESG-aligned
outcomes

Private Access to the Health
and Wellness Economy

At Health 45, we recognise that different investors have different needs.

That’s why we offer three distinct ways to participate – through a Limited Partnership, a Secured Loan Note, or an Investment Opportunity. As illustrated, each option flows into Cairngorm Vitality Limited.

Who is eligible to invest in Health45?

This opportunity is available strictly to individuals who qualify as High Net Worth or Self-Certified Sophisticated Investors under UK Financial Conduct Authority (FCA) regulations. You’ll be asked to confirm your status before proceeding.

What does Health45 invest in?
Health45 backs two high-growth health ventures:
  • A GLP-1 weight-loss platform expanding access to innovative obesity treatments.
  • A nutraceutical wellness business focused on scalable, high-margin products across Europe.
What returns can I expect?

Investors can access a fixed return of up to 45% over 3 years, depending on the chosen investment route and terms. Past performance is not indicative of future results. Capital is at risk.

Who manages Health45?

Health45 is led by experienced professionals with backgrounds in private equity, healthcare innovation, and compliance, ensuring each venture is managed with precision and strategic foresight.

Capitalising on Health Innovation:

The Health45 Approach

Request Investor Deck